Coral Laboratories [CORALAB] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison

Coral Laboratories Ltd.

BSE
Loading...

Gujarat Themis Biosyn Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Coral Laboratories Ltd. wins in 11 metrics, Gujarat Themis Biosyn Ltd. wins in 9 metrics, with 0 ties. Coral Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Coral Laboratories Ltd. Gujarat Themis Biosyn Ltd. Better
P/E Ratio (TTM) 11.06 73.73 Coral Laboratories Ltd.
Price-to-Book Ratio 0.73 13.36 Coral Laboratories Ltd.
Debt-to-Equity Ratio 0.41 27.04 Coral Laboratories Ltd.
PEG Ratio -0.20 -17.55 Coral Laboratories Ltd.
EV/EBITDA 4.44 52.76 Coral Laboratories Ltd.
Profit Margin (TTM) 15.97% 29.99% Gujarat Themis Biosyn Ltd.
Operating Margin (TTM) 5.58% 40.16% Gujarat Themis Biosyn Ltd.
EBITDA Margin (TTM) 5.58% 40.16% Gujarat Themis Biosyn Ltd.
Return on Equity 12.01% 19.64% Gujarat Themis Biosyn Ltd.
Return on Assets (TTM) 10.53% 16.19% Gujarat Themis Biosyn Ltd.
Free Cash Flow (TTM) $-41.67M $-251.22M Coral Laboratories Ltd.
Dividend Yield 0.29% 0.17% Coral Laboratories Ltd.
1-Year Return -18.38% 15.75% Gujarat Themis Biosyn Ltd.
Price-to-Sales Ratio (TTM) 1.77 22.23 Coral Laboratories Ltd.
Enterprise Value $532.28M $36.09B Gujarat Themis Biosyn Ltd.
EV/Revenue Ratio 0.61 22.65 Coral Laboratories Ltd.
Gross Profit Margin (TTM) 59.74% 83.29% Gujarat Themis Biosyn Ltd.
Revenue per Share (TTM) $245 $15 Coral Laboratories Ltd.
Earnings per Share (Diluted) $39.14 $4.40 Coral Laboratories Ltd.
Beta (Stock Volatility) 0.90 -0.17 Gujarat Themis Biosyn Ltd.

Coral Laboratories Ltd. vs Gujarat Themis Biosyn Ltd. Stock Performance Analysis

Loading Price Chart...

CORALAB
GUJTHEM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Coral Laboratories Ltd.2.22%0.75%9.98%18.09%9.54%13.35%
Gujarat Themis Biosyn Ltd.-0.57%-4.89%4.00%38.98%-1.40%-12.59%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Coral Laboratories Ltd.-18.38%101.77%4.69%9.89%526.74%564.59%
Gujarat Themis Biosyn Ltd.15.75%76.92%76.92%76.92%76.92%76.92%

Performance & Financial Health Analysis: Coral Laboratories Ltd. vs Gujarat Themis Biosyn Ltd.

MetricCORALABGUJTHEM
Market Information
Market Cap i₹1.53B₹35.41B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,56679,452
90 Day Avg. Volume i2,815106,446
Last Close₹500.65₹385.10
52 Week Range₹360.00 - ₹624.95₹225.05 - ₹479.00
% from 52W High-19.89%-19.60%
All-Time High₹1,190.00 (Jul 24, 2017)₹479.00 (Oct 27, 2025)
% from All-Time High-57.93%-19.60%
Growth Metrics
Quarterly Revenue Growth-0.06%0.10%
Quarterly Earnings Growth-0.55%-0.04%
Financial Health
Profit Margin (TTM) i0.16%0.30%
Operating Margin (TTM) i0.06%0.40%
Return on Equity (TTM) i0.12%0.20%
Debt to Equity (MRQ) i0.4127.04
Cash & Liquidity
Book Value per Share (MRQ)₹596.42₹24.29
Cash per Share (MRQ)₹286.45₹0.92
Operating Cash Flow (TTM) i₹106.44M₹970.68M
Levered Free Cash Flow (TTM) i₹241.56M₹487.72M
Dividends
Last 12-Month Dividend Yield i0.29%0.17%
Last 12-Month Dividend i₹1.50₹0.67

Valuation & Enterprise Metrics Analysis: Coral Laboratories Ltd. vs Gujarat Themis Biosyn Ltd.

MetricCORALAB (Apr 24, 2026)GUJTHEM (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i11.0673.73
Forward P/E i7.45N/A
PEG Ratio i-0.20-17.55
Price to Sales (TTM) i1.7722.23
Price to Book (MRQ) i0.7313.36
Market Capitalization
Market Capitalization i₹1.53B₹35.41B
Enterprise Value i₹532.28M₹36.09B
Enterprise Value Metrics
Enterprise to Revenue i0.6122.65
Enterprise to EBITDA i4.4452.76
Risk & Other Metrics
Beta i0.90-0.17
Book Value per Share (MRQ) i₹596.42₹24.29

Financial Statements Comparison: Coral Laboratories Ltd. vs Gujarat Themis Biosyn Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCORALAB (2025)GUJTHEM (2025)
Revenue/Sales i1.13B1.51B
Cost of Goods Sold i561.92M318.78M
COGS % of Revenue i49.6%21.1%
Gross Profit i569.87M1.19B
Gross Margin i50.4%78.9%
Research & Development iN/A34.37M
Operating Income (EBIT) i246.11M642.49M
Operating Margin i21.7%42.6%
EBITDA i353.48M713.04M
EBITDA Margin i31.2%47.3%
Pre-Tax Income i324.70M655.38M
Pre-Tax Income % of Revenue i28.7%43.5%
Income Tax i83.15M167.66M
Income Tax % of Revenue i7.3%11.1%
Net Income (Profit) i241.56M487.72M
Profit Margin i21.3%32.3%

Balance Sheet & Liquidity Metrics

MetricCORALAB (2025)GUJTHEM (2025)
Cash & Equivalents i34.06M116.94M
Total Current Assets i1.77B519.73M
Total Current Assets % of Revenue i156.0%34.5%
Total Current Liabilities i249.58M205.60M
Total Current Liabilities % of Revenue i22.1%13.6%
Long-Term Debt i0296.36M
Long-Term Debt % of Revenue i0.0%19.7%
Total Shareholders Equity i2.01B2.48B
Retained Earnings i1.71B2.37B
Retained Earnings % of Revenue i151.0%157.4%
Property, Plant & Equipment i217.44M411.30M

Cash Flow Statement Comparison

MetricCORALAB (2025)GUJTHEM (2025)
Operating Cash Flow i106.44M970.68M
Operating Cash Flow % of Revenue i9.4%64.4%
Capital Expenditures i-29.45M-1.16B
Free Cash Flow i-41.67M-251.22M
FCF Margin i-3.7%-16.7%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricCORALABGUJTHEM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i3.57M108.97M
Float Shares i802,60929.52M
% Held by Insiders i78.86%71.98%
% Held by Institutions i0.00%1.18%
% Held by Public i21.14%26.84%

Dividend Analysis & Yield Comparison: Coral Laboratories Ltd. vs Gujarat Themis Biosyn Ltd.

MetricCORALABGUJTHEM
Last 12-Month Dividend i₹1.50₹0.67
Last 12-Month Dividend Yield i0.29%0.17%
3-Year Avg Annual Dividend i₹1.17₹0.22
3-Year Avg Dividend Yield i0.26%0.17%
3-Year Total Dividends i₹3.50₹0.67
Ex-Dividend DateSep 19, 2025Sep 04, 2025